Estring Articles
Schering-Plough finally back in profit after Organon buy; exceeds expectations, pleasing shareholders
9 February 2009
S-P profit falls 21%, still up on predictions
27 October 2008
S-P profit down again on Organon charges
28 July 2008
Akzo Nobel's 2006 net income increases 20%
26 February 2007
Organon's NuvaRing approved in Australia
17 July 2006
Pharmacia & Paladin sign Canadian distribution deal
28 January 2002
Pharmacia Canada has named Paladin Labs as the exclusive Canadian distributorhyperprolactinemia, Estring (estradiol vagi
28 January 2002
USA Approves Estring
6 May 1996
Pharmacia & Upjohn's Estring approvable...
27 November 1995
Marriage Of Pharmacia And Upjohn Will Create New $13 Bill Drug Group
4 September 1995
Estring Launch
14 November 1994
KABI PHARMACIA AND LEIRAS JV
5 July 1993
Showing 1-13 of 13 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
